BDBM476501 (2S)-N-[5-chloro-2-(1H-tetrazol-1- yl)benzyl]-4-(4,4-dimethyl-5-phenyl- 4,5-dihydro-1,3-oxazol-2-yl)-1-(6- piperidin-1-yl-D-norleucyl)piperazine- 2-carboxamide::US10875851, Example 157

SMILES CC1(C)N=C(N2CCN(C(=O)[C@H](N)CCCCN3CCCCC3)[C@H](C(=O)NCc3cc(Cl)ccc3-n3cnnn3)C2)OC1c1ccccc1

InChI Key InChIKey=ORGYHXJSMFZHQZ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 476501   

TargetCoagulation factor XII(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 476501BDBM476501((2S)-N-[5-chloro-2-(1H-tetrazol-1- yl)benzyl]-4-(4...)
Affinity DataIC50: 54.8nMAssay Description:The effectiveness of a compound of the present invention as an inhibitor of Coagulation Factor XIIa can be determined using a relevant purified serin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
US Patent